Who owns ATHIRA PHARMA INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Athira Pharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Athira Pharma stock

Who bought or sold ATHIRA PHARMA INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Perceptive Advisors 5.4M $13M 13% Dec 2023
 View chart
Baker Bros. Advisors 3.2M $7.7M 0% Dec 2023
 View chart
Vanguard Group 1.7M $4.1M 0% Dec 2023
 View chart
Simplify Asset Management 1.5M $3.6M 0% Dec 2023
 View chart
Propel Bio Management 1.5M $3.6M 100% Dec 2023
 View chart
BML Capital Management 1.5M $3.5M -15% Dec 2023
 View chart
Tang Capital Management 1.2M $2.8M 227% Dec 2023
 View chart
BlackRock 663k $1.3M -1% Sep 2023
 View chart
Millennium Management 456k $1.1M -39% Dec 2023
 View chart
Pathstone Family Office 426k $860k 0% Sep 2023
 View chart
Pathstone Holdings 372k $905k 100% Dec 2023
 View chart
Citadel Advisors 366k $890k -3% Dec 2023
 View chart
Dimensional Fund Advisors 347k $843k -35% Dec 2023
 View chart
Two Sigma Investments 304k $739k 14% Dec 2023
 View chart
GSA Capital Partners 301k $731k 1% Dec 2023
 View chart
Two Sigma Advisers 299k $726k 7% Dec 2023
 View chart
Geode Capital Management 283k $573k -3% Sep 2023
 View chart
Renaissance Technologies 283k $571k -36% Sep 2023
 View chart
Jacobs Levy Equity Management 270k $657k -10% Dec 2023
 View chart
Bridgeway Capital Management 186k $375k 29% Sep 2023
 View chart
Nan Fung Group Holdings 180k $364k 1429% Sep 2023
 View chart
Laird Norton Tyee Trust 179k $361k 21% Sep 2023
 View chart
Barclays 174k $440k -60% Dec 2023
 View chart
Advisor Group Holdings 170k $413k 20% Dec 2023
 View chart
Potomac Capital Management 150k $364k 101% Dec 2023
 View chart
Acadian Asset Management 140k $281k -43% Sep 2023
 View chart
State Street Corporation 108k $218k -9% Sep 2023
 View chart
Verition Fund Management 100k $202k -10% Sep 2023
 View chart
Susquehanna International 94k $189k -19% Sep 2023
 View chart
Bristlecone Advisors 85k $207k 0% Dec 2023
 View chart
CornerCap Investment Counsel 75k $183k 0% Dec 2023
 View chart
Morgan Stanley 62k $125k -46% Sep 2023
 View chart
Northern Trust 55k $110k -5% Sep 2023
 View chart
Clarius 54k $130k 36% Dec 2023
 View chart
Bank of America Corporation 49k $118k -89% Dec 2023
 View chart
William Blair $ Company 36k $88k 0% Dec 2023
 View chart
Royal Bank of Canada 36k $92k 1740% Dec 2023
 View chart
Rothschild Investment Corp 34k $68k 0% Sep 2023
 View chart
Levin Easterly Partners 34k $81k 0% Dec 2023
 View chart
Integrity Financial Corp 33k $80k 0% Dec 2023
 View chart
Springbok Capital Management 32k $65k 11% Sep 2023
 View chart
Jane Street 23k $55k 100% Dec 2023
 View chart
Forefront Analytics 21k $42k 0% Sep 2023
 View chart
Massey, Quick & Co 21k $50k 0% Dec 2023
 View chart
Journey Strategic Wealth 21k $50k 0% Dec 2023
 View chart
Sargent Investment Group 18k $44k -12% Dec 2023
 View chart
Cubist Systematic Strategies 17k $41k -14% Dec 2023
 View chart
Bank of New York Mellon 16k $39k 0% Dec 2023
 View chart
Occudo Quantitative Strategies 16k $38k -26% Dec 2023
 View chart
Ameriprise Financial 15k $31k 0% Sep 2023
 View chart
American Century Companies 15k $31k 100% Sep 2023
 View chart
Federated Investors 14k $34k -6% Dec 2023
 View chart
Private Advisor 13k $32k 100% Dec 2023
 View chart
HighTower Advisors 13k $30k -1% Dec 2023
 View chart
Lindbrook Capital 9.7k $24k 0% Dec 2023
 View chart
Qube Research & Technologies 4.7k $9.4k -92% Sep 2023
 View chart
Point72 Asia 3.1k $7.5k 100% Dec 2023
 View chart
Rhumbline Advisers 1.5k $3.7k 0% Dec 2023
 View chart
FMR 1.0k $2.0k -67% Sep 2023
 View chart
UBS Group 932.00 $2.3k -99% Dec 2023
 View chart
McIlrath & Eck 825.00 $2.0k 0% Dec 2023
 View chart
Wells Fargo & Company 234.00 $568.994400 -98% Dec 2023
 View chart
Tower Research Capital 162.00 $326.997000 100% Sep 2023
 View chart
Householder Group Estate & Retirement Specialist 150.00 $0 0% Dec 2023
 View chart
Jpmorgan Chase & Co 143.00 $347.003800 -86% Dec 2023
 View chart
Citigroup 75.00 $182.002500 0% Dec 2023
 View chart

Who sold out of Athira Pharma?

Fund or Company Name Date Sold Shares Held Valued At
Point72 Asset Management Sep 2023 908k $1.8M
Acuitas Investments Sep 2023 150k $302k
Old Mission Capital Jun 2023 81k $240k
Y-Intercept Jun 2023 37k $110k
Ergoteles Jun 2023 34k $99k
Brighton Jones Sep 2023 32k $65k
Marquette Asset Management Sep 2023 31k $62k
D. E. Shaw & Co Sep 2023 30k $61k
Algert Coldiron Investors Sep 2023 28k $56k
Squarepoint Ops Sep 2023 11k $22k
Ohio Pers Sep 2023 9.2k $19k
Quantbot Technologies Jun 2023 1.6k $4.7k
Pnc Financial Services Sep 2023 1.5k $3.0k